Skip to content
doser

Blog hub

Plain-language coverage of GLP-1 research and regulatory news, plus notes from the Doser team on how and why the app works the way it does.

The Doser blog has three kinds of post. News covers approvals, label changes and supply updates, summarized from regulator announcements and linked to the original notices. Research explains new GLP-1 studies without hype: what was tested, in whom, what was found and what it does not tell you yet. Doser updates records what changed in the app and why. Posts are written by the Doser team in plain language, and any medical information comes from named sources. Nothing here is medical advice, and no post will tell you how much to take.

Categories

Posts

Featured

Get Doser for Android

DoserGLP-1 shot tracker. No ads.

Install